Central Retinal Vein Occlusion in Younger Swedish Adults: Case Reports and Review of the Literature
- PMID: 28603574
- PMCID: PMC5447937
- DOI: 10.2174/1874364101711010089
Central Retinal Vein Occlusion in Younger Swedish Adults: Case Reports and Review of the Literature
Abstract
Purpose: To investigate associated systemic diseases, other conditions, visual outcome, ocular complications and treatment in Swedish patients younger than 50 years with central retinal vein occlusion (CRVO) and reviewing the literature.
Methods: Twenty-two patients with CRVO, younger than 50 years, were examined with full-field electroretinography (ERG) within 3 months after a thrombotic event, or were periodically examined and were observed for at least 6 months. In 18 of these patients, the initial retinal ischemia was studied using the cone b-wave implicit time in the 30 Hz flicker ERG. Fifteen patients also underwent fluorescein angiography. Optical coherence tomography (OCT) was performed in 14 patients. The patients studied were divided into two groups, non-ischemic and ischemic, which were compared. All patients underwent ocular and systemic examination, as well as complete screening for thrombophilic risk factors.
Results: Of the 22 patients, 15 had non-ischemic type of CRVO and 7 the ischemic type. Patients with non-ischemic CRVO showed significantly improved visual acuity (VA) at the final examination (p=0.006). Patients with ischemic CRVO showed no significant reduction in VA at the final examination (p=0.225). Systemic hypertension (27% in non-ischemic CRVO and 29% in ischemic CRVO) was the most prevalent systemic risk factor for CRVO. The mean central foveal thickness (CFT) decreased significantly from 402.3±136.2 (µm) at the initial examination to 243.8±48.1 (µm) at the final examination in the non-ischemic group (p=0.005). The mean initial CFT was 444.5±186.1 (µm) in the ischemic CRVO group, which decreased to 211.5±20.2 (µm) at the final visit (p=0.068). Pigment dispersion syndrome (PDS)/pigmentary glaucoma (PG), ocular hypertension and dehydration were equally frequent; four patients each (18%) out of 22. The clinical course of 4 younger patients with PDS/PG are described.
Conclusion: The patients with non-ischemic CRVO showed significantly improved VA and significantly decreased CFT at the final examination. Systemic hypertension was the most prevalent risk factor for CRVO. Younger adults with CRVO also had a high prevalence of PDS/PG, ocular hypertension and dehydration. This study highlights the importance of careful IOP monitoring, and the need to investigate possible PDS/PG and to obtain an accurate history of the patient including alcohol intake and intense exercise.
Keywords: Central retinal vein occlusion; Dehydration; Pigment dispersion syndrome/pigmentary glaucoma; Younger Swedish adults.
Figures


Similar articles
-
Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.Retina. 2005 Oct-Nov;25(7):846-50. doi: 10.1097/00006982-200510000-00005. Retina. 2005. PMID: 16205562
-
Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.Retina. 2007 Feb;27(2):180-9. doi: 10.1097/01.iae.0000237584.56552.1c. Retina. 2007. PMID: 17290200
-
Early panretinal photocoagulation for ERG-verified ischaemic central retinal vein occlusion.Acta Ophthalmol. 2013 Feb;91(1):37-41. doi: 10.1111/j.1755-3768.2011.02320.x. Epub 2011 Dec 16. Acta Ophthalmol. 2013. PMID: 22176715
-
Prevalent misconceptions about acute retinal vascular occlusive disorders.Prog Retin Eye Res. 2005 Jul;24(4):493-519. doi: 10.1016/j.preteyeres.2004.12.001. Prog Retin Eye Res. 2005. PMID: 15845346 Review.
-
[Treatment modalities in central retinal vein occlusion].Harefuah. 2010 Apr;149(4):245-50, 261, 260. Harefuah. 2010. PMID: 20812500 Review. Hebrew.
Cited by
-
Central retinal vein occlusion in a young healthy COVID-19 patient: A case report.Am J Ophthalmol Case Rep. 2020 Dec;20:100992. doi: 10.1016/j.ajoc.2020.100992. Epub 2020 Nov 16. Am J Ophthalmol Case Rep. 2020. PMID: 33225111 Free PMC article.
-
Oscillatory potential findings in patients with acute ischaemic central retinal vein occlusion.BMJ Open Ophthalmol. 2024 Aug 13;9(1):e001582. doi: 10.1136/bmjophth-2023-001582. BMJ Open Ophthalmol. 2024. PMID: 39142698 Free PMC article.
-
Clinical efficacy evaluation of treatment of different degrees of retinal vein occlusion with ranibizumab combined with an argon ion laser.Exp Ther Med. 2019 Mar;17(3):1563-1568. doi: 10.3892/etm.2018.7125. Epub 2018 Dec 21. Exp Ther Med. 2019. PMID: 30783422 Free PMC article.
-
Insights to Ang/Tie signaling pathway: another rosy dawn for treating retinal and choroidal vascular diseases.J Transl Med. 2024 Oct 4;22(1):898. doi: 10.1186/s12967-024-05441-y. J Transl Med. 2024. PMID: 39367441 Free PMC article. Review.
-
Clinical Features of Central Retinal Vein Occlusion in Young Patients.Ophthalmol Ther. 2022 Aug;11(4):1409-1422. doi: 10.1007/s40123-022-00534-7. Epub 2022 Jun 13. Ophthalmol Ther. 2022. PMID: 35697973 Free PMC article. Review.
References
-
- Yau J.W., Lee P., Wong T.Y., Best J., Jenkins A. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Int. Med. J. 2008;38:904–910. - PubMed
-
- David R., Zangwill L., Badarna M., Yassur Y. Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica. 1988;197:69–74. - PubMed
-
- Priluck I.A., Robertson D.M., Hollenhorst R.W. Long-term follow-up of occlusion of the central retinal vein in young adults. Am. J. Ophthalmol. 1980;90:190–202. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous